How Do We Define Cure of Diabetes?
By John B. Buse, S. Caprio, W. Cefalu, Antonio Ceriello, S. Del Prato, Silvio E. Inzucchi, S. Mclaughlin, G. Phillips, R. Robertson, F. Rubino and 2 more. Diabetes Care, 2009
983 citations recorded by the source corpus.
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved? A consensus group comprised of experts in pediatric and adult endocrinology, diabetes education, transplantation, metabolism, bariatric/metabolic surgery, and (for another perspective) hematology-oncology met in June 2009 to discuss these issues. The group considered a wide variety of questions, including whether it is ever accurate to say that a chronic illness is cured; what the definitions of management, remission, or cure might be; whether goals of managing comorbid conditions revert to those of patients without diabetes if someone is …
Subfields: Endocrinology, Diabetes and Metabolism, Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/b03a05fbc8ba737c96b984d9e1aa06eaeb4327a9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- V. Yumuk
- Edward W. Gregg
- Haiying Chen
- Martin D. Fried
- Lynne E. Wagenknecht
- Jeanne M. Clark
- Yury Yashkov
- G. Taroncher-Oldenburg
Citations in the corpus
- Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery (2014, background): “In case of T2DM patients, use of anti-diabetic medication and/ or insulin should be with no delays adjusted post-operatively to minimize risks of hypoglycaemia.”
- Health Benefits of Gastric Bypass Surgery after 6 Years (2012, neutral): “High LDL-C 9/334 3 (1-5) 13/328 4 (1-7) 38/321 12 (7-17) 66/265 25 (18-32) 44/248 18 (12-24) 71/237 30 (22-38)”
- Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations (2016, background): “0%, respectively, off all diabetes medications, and maintenance of these glycemic levels for at least 1 year (97).”
- Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019, neutral): “(177,178)din people undergoingweight loss treatment.”
- Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes (2012, positive): “The appropriate definition of diabetes remission remains an area of ambiguity and debate.(9) For these analyses, we adopted the American Diabetes Association’s definition, achievement of glycemia below the diabetic range in the absence of active pharmacological treatment or surgical therapy.”